MOLN:SWX
Molecular Partners AG
CHF 3.07
arrow_upward
+0.33%(+0.0100) 1D
Oct 20, 2:28:55 PM GMT+2 · CHF
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for MOLN...
Open
CHF 3.08
High
CHF 3.10
Low
CHF 3.05
Mkt. cap
123.95M
Avg. vol.
10.48K
Volume
3.63K
52-wk high
CHF 3.96
52-wk low
CHF 2.66
EPS
-CHF 1.37
Shares outstanding
40.37M
No. of employees
134
Open
CHF 3.08
High
CHF 3.10
Low
CHF 3.05
Mkt. cap
123.95M
Avg. vol.
10.48K
Volume
3.63K
52-wk high
CHF 3.96
52-wk low
CHF 2.66
EPS
-CHF 1.37
Shares outstanding
40.37M
No. of employees
134
News stories
From web sources and news partners
FOREX.com
·
34 minutes ago
USD/JPY and Nasdaq Price Outlook: Key Levels to Watch
CNBC
·
12 minutes ago
Investors look to earnings to reset the bull market. The key level to watch on the S&P 500
ChartMill
·
29 minutes ago
S&P 500 Premarket Movers: Gainers and Losers on Oct. 20, 2026
شبكة تواصل الإخبارية
·
3 hours ago
Dow Jones futures rise as markets bet on Fed rate hold, tech recovery | FXStreet
Profile
Molecular Partners AG is a clinical-stage biopharmaceutical company based in Zürich, Switzerland. The company is developing a new class of potent, specific and versatile small-protein therapies called DARPins, with potential clinical applications in a range of disease areas including oncology, immuno-oncology, ophthalmology, and infectious diseases. Molecular Partners currently has two DARPin molecules in clinical development, and a broad pipeline of molecules in preclinical development. Wikipedia
About Molecular Partners AG